Publicly trading company, specializing in research, development, production, and distribution of solutions for Genomics, Proteomics and Diagnostics, currently developing a platform comprised of molecular human diagnostic tools for various diseases.
Acrongenomics Inc. (OTCBB: AGNM), is a publicly traded company, specializing in the field of Molecular Diagnostics by integrating nanotechnology with molecular biology, the so called Nano-JETA platform. Company’s latest achievements include the completion of its unique and unsurpassed Neo-EpCAM™ Cancer detection kit which overcomes all known problems arising from conventional PCR, ELISA and Real Time PCR. The unparalleled technology used has been proven via extended validated studies in HER1, HER2, HER3, HER4, p53, vEGF as well as HPV, EBV, and HBV.
Links
